Drug-containing serum of Xinfeng capsules protect against H9C2 from death by enhancing miRNA-21 and inhibiting toll-like receptor 4/phosphorylated p-38 (p-p38)/p-p65 signaling pathway and proinflammatory cytokines expression

Journal of Traditional Chinese Medicine · Published 2018-06-01 · DOI 10.1016/s0254-6272(18)30626-5

Authors being retrieved — see the publisher record. https://doi.org/10.1016/s0254-6272(18)30626-5

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2018

Related articles